20.05.2025/ 08:01 CET/CEST

Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No596/2014, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement.
______________________________________________________________________________________________________________

Not for release, publication or distribution, directly or indirectly, in or into the United States of America, Australia, Canada or Japan or any other jurisdiction in which such release, publication or distribution would be unlawful. The important notices at the end of this release must be observed.

______________________________________________________________________________________________________________

Ad-hoc: Cantourage significantly increases profitability and revenue - EBITDA margin of 11 to 13 % in the first quarter of 2025

Berlin, 20 May 2025 - Cantourage Group SE (hereinafter ‘Cantourage’, ISIN:DE000A3DSV01, www.cantourage.com), Europe's leading listed medical cannabis company, reports an EBITDA margin of 11 to 13% for the first quarter of 2025 based on preliminary, internal figures (unaudited, non consolidated). Revenues in the same period amounted to more than EUR 25 million; as of the end of April, cumulative revenues already exceeded EUR 36 million, confirming both the economic scalability of Cantourage's business model and the continued strongdemand in its core markets.

 ________________________________________________________________________________________________________

About Cantourage

Cantourage is a leading European company for the production and distribution of medical cannabis. Cantourage enables growers worldwide to sell products in European medical markets. Founded in 2019, the company works with more than 60 cannabis growersfrom 18 countries. Cantourage ensures the highest pharmaceutical quality standards along the value chain and offers products in all relevant market segments: dried flowers, extracts, dronabinol and cannabidiol. The company has been listed on the Frankfurt Stock Exchange since November 11, 2022 and is listed under the ticker symbol “HIGH”.

______________________________________________________________________________________________________________

Press contacts

PiaSenkel | pia.senkel@tonka-pr.com | +49 (0) 173 3702649
Klaas Geller | klaas.geller@tonka-communications.de | +49 (0) 176 74717519

______________________________________________________________________________________________________________

Important information:
This announcement contains information within the meaning of Article 17 of Regulation (EU) No 596/2014 (Market Abuse Regulation). This announcement does not constitute an offer to the public or an advertisement for a public offer to sell securities, in particular not withinthe meaning of Regulation (EU) 2017/1129 (Prospectus Regulation). This ad hoc announcement was published via the electronic informationdistributor EQS News.